Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-thyroid Drug Regimens in Young People
NCT01436994Phase 3Completed
- Sponsor
- Newcastle Hospitals NHS Foundation Trust
- Start
- Jul 2004
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of carbimazole in thyrotoxicosis (2 arms), sponsored by Newcastle Hospitals NHS Foundation Trust. Primary endpoint: Stability of blood thyroid stimulating hormone (TSH) concentrations at 2.5 years. Started Jul 2004; status: completed.
02
Drugs
carbimazole
03
Conditions
thyrotoxicosis
Beyond the preview
Go deeper on NCT01436994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01436994.